New EPS patient with leukemia has not received her medication since November: it costs five million pesos
Since she was diagnosed with chronic myeloid leukemia (CML), doctors prescribed her Dasatinib, a medication that costs around five million pesos on the market.
TL;DR
- A patient with chronic myeloid leukemia (LMC) has not received her medication, Dasatinib, since November 2025.
- Dasatinib is a crucial medication for her treatment and costs around five million pesos.
- The Nueva EPS has failed to deliver the medication for four months, causing the patient daily pain.
- A judicial ruling ordering the Nueva EPS to provide the drug has been disregarded.
- The patient's son reports that the EPS has not contacted them or delivered the medication since the ruling.
- The interventor of the Nueva EPS was recently ordered arrested for failing to provide urgent medical care to another patient.
- The Tribunal Superior de Buga previously determined that the Nueva EPS has abandoned its users.